Oxymetazoline hydrochloride ophthalmic solution (RVL Pharmaceuticals)
盐酸羟甲唑啉滴眼液 (RVL Pharmaceuticals)
Report date: 2025/12/24 10:32:48
Base Information
Drug NameOxymetazoline hydrochloride ophthalmic solution (RVL Pharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2020/07/08
Country/Territory +[12]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesRevitalid Inc
China Registration ClassN/A
Develop Information
Active CompaniesSanten SasRvl Pharmaceuticals IncSanten Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A